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were assayed by high-pressure liquid chromatography by Dr. G. Smaldone (Stony Brook, NY), who was blinded to the source of individual samples. Only in one sample from one of our HCWs was pentamidine detected at a level of 1.625 npjm@ml, approximately the same as the lower exposure levels in the study by O'Riordan and Smaldone. During the sampling day this HCW had been present during 35 individual treatments and had been present during some 790 treatments over the previous month. A subsequent sample on this HCW was negative later the same week. We consider administration of AP via the Fisoneb system, even in a high-volume clinic such as ours, to have negligible effects on individual HCWs. We agree that low-dose environmental exposure is inevitable, and that occasional higher levels due to environmental spillover should be expected, although they can be minimized. More important, we believe that breath-activated nebulizer systems, such as the Fisoneb system, are preferable because their very design significantly reduces environmental spillage, since they turn off after inspiration ceases or if coughing occurs. We thank Dr. McIvor and his coworkers for their interest in our study and for sharing their data.
R. Andrew
Analyzing random HCW urine specimens (assayed at our laboratory) from a large treatment center (up to 1,200 treatments per HCW per month), they found only one positive urine test for pentamidine in an HCW. There are three possible explanations for the differences in the two studies:
1. The Toronto group administered all treatments via the Fisoneb system, an ultrasonic nebulizer that only produces aerosol when a patient holds down a switch on the device. In our article we suggest that the most likely explanation for high-level intermittent exposure of HCWs to pentamidine is "disconnected nebulization" (ie, when a patient removes the device from his mouth in order to cough, he may neglect to switch it o@. Because of the design of the Fisoneb, such disconnected nebulization may be less likely to occur.
2. Another important difference between the studies is the design of the treatment rooms. We used a treatment room with an exhaust system that operated at 60 cu ftlmin. In contrast, McIvor et all had a specially designed treatment room that exhausted air at 450 cu ftl min during treatments. The frequency of air exchanges may be important. In our initial report of positive results in urine specimens from in HCWqP levels were higher at Stony Brook, where fewer treatments were administered but where the frequency of air exchanges was also less when compared with a Miami center, which had a more effective air exchange system but at which workers performed a much larger number of treatments.
3. In our study, HCWs supervised the treatments. In the Toronto study, the HCW was not in the room during treatments, which were self-administered by the patients. In general, because the possibility of disconnected nebulization is greatest during the absence of HCWs from the treatment room, it is usually recummended that HCWs not enter a room until two air exchanges have taken place following completion of an unsupervised treatment. This would take 20 min with our system. In Toronto, the more efficient exhaust system would markedly reduce the waiting time for two air exchanges. Thus, patient-administered treatments are likely to be much less hazardous to HCWs in Toronto than they wor~ld be under our system.
While the Toronto group should be congratulated on the effectiveness of their system in avoiding high exposures of HCWs to pentamidine, the conditions under which our HCWs administer pentamidine are, we believe, more typical of clinical practice than the conditions under which the Toronto group practices. Nevertheless, the simple precautions we advocated in our article can reduce the likelihood of high exposures with our system. We agree that chronic low-level exposure to pentamidine is inevitable and that the long-term consequences, if any, of this exposure are unclear at the present time. 
Adenoid Cystic Carcinoma Mimicking a Dermoid or Hydatid Cyst 7b the Editor:
A 75-yearold nonsmoking male patient was admitted with the complaints of backache and clear, watery discharge on two occasions during coughing. Chest radiography revealed a mass lesion occupying almost all of the left hemithorax. A multiloculated cyst with solid components and calcified foci was observed on computed tomography of the thorax (Fig 1) . Surgery was performed on the basis of the preliminary diagnosis of hydatid or dermoid cyst. Adenoid cystic carcinoma was found in the pathologic examination.
Many cases of adenoid cystic carcinoma arising from the bronchial tree haie been reported.^; Few reports have described calcification. 
Tetracycline Pleurodesis

Ib the Fditoc
We read with interest the editorial by Heffier and Unruh.' which appeared in the January 1992 issue of Chest. The authors voiced their regret that injectable tetracycline hydrochloride has been discontinued by the sole manufacturer of the drug. This drug was used for patients with pneumothoraces and as the preferred method of chemical pleurodesis in patients with malignant pleural effusions. ' Injectable tetracycline was not available to us for many years, but we replaced it with sterile tetracycline powder from D.S.A. Company (Hamburg, Germany). The vials are prepared as follows: (1) They remain at 120°C for 20 min. (2) They are cleaned externally with 4 percent chlorhexidine. (3) The rubber caps and aluminum seals are submitted to the same process. (4) The vials are transferred under ultraviolet light to a sterile area. where they are filled with the powder.
Following the Sahn protom1,J we treated 14 patients with malignant a s i o n . We dissolved 1.5 to 2.0 g (20 to 30 m & g ) of tetracycline powder in 50 ml of saline, obtaining a solution with a pH of 2.2. The solution was instilled into the pleural cavity after intrapleural administration of 300 mg of lidocaine and administration of parented analgesics. The tube was clamped for 2 h, and the patient was repositioned frequently.
Four of our 14 patients were men with an average age of 69 years and 10 were women with an average age of 70 years Ten patients had adenocarcinoma, and four had squamous cell carcinoma. AU patients reported pain: mild in ten cases, moderate in two cases, and severe in two cases In the 12 patients with fever, the temperature varied from 37.2% to 39.6OC during a period of 1 to 3 days The pleural tube was retained for 1 to 4 days after the procedure.
Follow-up data were available on ten patients In eight there was no relapse of effusion in a follow-up period of 7 to 180 days (average, 43 days). We did not use preventive antibiotics, and we did not observe local or systemic infection in these ten cases.
We think that the tetracycline powder can be used as a highly a c i e n t and lowcost alternative in these patients 
Abteilung P n e u U e d o g i e .
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--w 1 HefFner JE. Unruh LC. Tetracycline pleurodesis: adios, h e l l .
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Erratum
The editors of Chart wish to apologize to N. Tony Eissa. M.D..
for misspelling his name in his article entitled "Effects of PEEP on Respiratory Mechanics after Open Heart Surgery" (Chart 1992; 102:227-33).
